Clinical heart transplantation without routine endomyocardial biopsy

Area of Science:

• Cardiology
• Transplantation Medicine
• Biomedical Engineering

Background:

• Routine endomyocardial biopsy (EMB) is standard for detecting cardiac allograft rejection.
• Noninvasive methods are sought to reduce EMB risks and costs.
• Early detection of rejection is crucial for graft survival.

Purpose of the Study:

• To evaluate the efficacy of noninvasive diagnostic techniques (intramyocardial electrogram and echocardiography) in replacing routine endomyocardial biopsies for cardiac allograft rejection monitoring.
• To assess the diagnostic safety and potential reduction in EMB frequency using these noninvasive methods.

Main Methods:

• A prospective study involving 32 heart transplant patients over 6 months.
• Intramyocardial electrogram (IMEG) amplitude decrease (>8%) and Te interval prolongation (>20 msec) were used as noninvasive rejection indicators.
• Routine EMBs were performed but blinded to the clinical team; pathologist intervention was optional.

Main Results:

• 22 out of 27 rejection episodes were diagnosed noninvasively.
• No false negative IMEG results were observed, yielding a 100% negative predictive value.
• EMB frequency could be reduced by 90% while maintaining diagnostic safety.

Conclusions:

• Noninvasive monitoring with IMEG and echocardiography can justify omitting routine EMBs when cardiac function is normal.
• EMB remains necessary for inconclusive noninvasive results or suspected false positives (infection, arrhythmias).
• This strategy enhances diagnostic safety and significantly reduces the need for invasive procedures.